After a demanding, 200-kilometre ride from Montreal to Quebec City, 1,100 cyclists in the 9th annual Enbridge Ride to Conquer Cancer raised $4.1 million for the JGH and its partners across Quebec.
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.
The Segal Cancer Centre at the JGH has distinguished itself as the only medical centre in Quebec to serve the needs of adolescents and young adults with cancer by providing a dedicated clinic staffed by a multi-disciplinary team.
One of Hope & Cope’s newest initiatives, the Breast & Bone Health Program, identifies women who have had breast cancer and are at risk for bone fragility.
Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.
The Jewish General Hospital’s French connection has been strengthened with the visit of six senior members of staff from the Regional Cancer Centre of the University Hospital Centre of Poitiers.